TOP CATEGORY: Chemicals & Materials | Life Sciences | Banking & Finance | ICT Media

Global Biopharmaceutical Contract Manufacturing Market Research Report 2022

Global Biopharmaceutical Contract Manufacturing Market Research Report 2022

  • Category:Life Sciences
  • Published on : 25 November 2022
  • Pages :90
  • Formats:
  • Report Code:SMR-7495785
OfferClick for best price

Best Price: $2320

Biopharmaceutical Contract Manufacturing Market Size

Market Analysis and Insights: Global Biopharmaceutical Contract Manufacturing Market

The global Biopharmaceutical Contract Manufacturing market size is projected to reach US$ XX million by 2027, from US$ XX million in 2020, at a CAGR of XX% during 2021-2027.

With industry-standard accuracy in analysis and high data integrity, the report makes a brilliant attempt to unveil key opportunities available in the global Biopharmaceutical Contract Manufacturing market to help players in achieving a strong market position. Buyers of the report can access verified and reliable market forecasts, including those for the overall size of the global Biopharmaceutical Contract Manufacturing market in terms of revenue.

On the whole, the report proves to be an effective tool that players can use to gain a competitive edge over their competitors and ensure lasting success in the global Biopharmaceutical Contract Manufacturing market. All of the findings, data, and information provided in the report are validated and revalidated with the help of trustworthy sources. The analysts who have authored the report took a unique and industry-best research and analysis approach for an in-depth study of the global Biopharmaceutical Contract Manufacturing market.

Global Biopharmaceutical Contract Manufacturing Scope and Market Size

Biopharmaceutical Contract Manufacturing market is segmented by players, region (country), by Type and by Application. Players, stakeholders, and other participants in the global Biopharmaceutical Contract Manufacturing market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on revenue and forecast by Type and by Application for the period 2017-2028.
Segment by Type
Growth Factors
Interferons
Monoclonal Antibodies
Recombinant Hormones
Vaccines
Insulin
Others
Segment by Application
Autoimmune Diseases
Oncology
Metabolic Diseases
Ophthalmology
Cardiovascular Diseases
Infectious Diseases
Neurology
Respiratory Disorders
Others
By Region
North America
United States
Canada
Europe
Germany
France
UK
Italy
Russia
Nordic Countries
Rest of Europe
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia
Rest of Asia
Latin America
Mexico
Brazil
Rest of Latin America
Middle East & Africa
Turkey
Saudi Arabia
UAE
Rest of MEA
By Company
Lonza Group
Baxter Biopharma Solutions
Samsung
Fujifilm Diosynth Biotechnologies
Boehringer Ingelheim
Patheon
Rentschler Biotechnologie
Biomeva
Probiogen
Cytovance Biologics
KBI Biopharma
WuXi Biologics
Abzena

The information for each competitor/Company Profile includes:

  • Company Overview
  • Business Strategy
  • Key Product Offerings
  • Financial Performance
  • Key Performance Indicators
  • Risk Analysis
  • Recent Development
  • Regional Presence
  • SWOT Analysis 

The content of the study subjects includes a total of 15 chapters:

Chapter 1, describes Biopharmaceutical Contract Manufacturing product scope, market overview, market opportunities, market driving force, and market risks.

Chapter 2, profiles the top manufacturers of Biopharmaceutical Contract Manufacturing, with price, sales, revenue, and global market share of Biopharmaceutical Contract Manufacturing from 2019 to 2022.

Chapter 3, the Biopharmaceutical Contract Manufacturing competitive situation, sales, revenue, and global market share of top manufacturers are analyzed emphatically by landscape contrast.

Chapter 4, the Biopharmaceutical Contract Manufacturing breakdown data are shown at the regional level, to show the sales, revenue and growth by regions, from 2017 to 2028.

Chapters 5 and 6, to segment the sales by Type and application, with sales market share and growth rate by type, and application, from 2017 to 2028.

Chapters 7, 8, 9, 10, and 11, to break the sales data at the country level, with sales, revenue, and market share for key countries in the world, from 2017 to 2022. and the Biopharmaceutical Contract Manufacturing market forecast, by regions, type, and application, with sales and revenue, from 2023 to 2028.

Chapter 12, the key raw materials and key suppliers, and industry chain of Biopharmaceutical Contract Manufacturing.

Chapter 13, 14, and 15, to describe Biopharmaceutical Contract Manufacturing sales channel, distributors, customers, research findings and conclusion, appendix and data source.

Key Indicators Analysed:

  • Market Players & Competitor Analysis: The report covers the key players of the industry including Company Profile, Product Specifications, Production Capacity/Sales, Revenue, Price and Gross Margin 2016-2027 & Sales with a thorough analysis of the market?s competitive landscape and detailed information on vendors and comprehensive details of factors that will challenge the growth of major market vendors.
  • Global and Regional Market Analysis: The report includes Global & Regional market status and outlook 2016-2027. Further the report provides break down details about each region & countries covered in the report. Identifying its sales, sales volume & revenue forecast. With detailed analysis by types and applications.
  • Market Trends: Market key trends which include Increased Competition and Continuous Innovations.
  • Opportunities and Drivers: Identifying the Growing Demands and New Technology
  • Porters Five Force Analysis: The report provides with the state of competition in industry depending on five basic forces: threat of new entrants, bargaining power of suppliers, bargaining power of buyers, threat of substitute products or services, and existing industry rivalry.

Reasons to Purchase this Report:

  • Estimates 2022-2027 2021-2025 Biopharmaceutical Contract Manufacturing Report on, Status and Forecast, by Players, Types and Applications market development trends with the recent trends and SWOT analysis
  • Market dynamics scenario, along with growth opportunities of the market in the years to come
  • Market segmentation analysis including qualitative and quantitative research incorporating the impact of economic and policy aspects
  • Regional and country level analysis integrating the demand and supply forces that are influencing the growth of the market.
  • Market value (USD Million) and volume (Units Million) data for each segment and sub-segment
  • Competitive landscape involving the market share of major players, along with the new projects and strategies adopted by players in the past five years
  • Comprehensive company profiles covering the product offerings, key financial information, recent developments, SWOT analysis, and strategies employed by the major market players
  • 1-year analyst support, along with the data support in excel format.

Research Methodology:

The research methodology used to estimate and forecast this market begins by capturing the revenues of the key players and their shares in the market. Various secondary sources such as press releases, annual reports, non-profit organizations, industry associations, governmental agencies and customs data, have been used to identify and collect information useful for this extensive commercial study of the market. Calculations based on this led to the overall market size. After arriving at the overall market size, the total market has been split into several segments and subsegments, which have then been verified through primary research by conducting extensive interviews with industry experts such as CEOs, VPs, directors, and executives. The data triangulation and market breakdown procedures have been employed to complete the overall market engineering process and arrive at the exact statistics for all segments and subsegments.

TABLE OF CONTENTS

1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Biopharmaceutical Contract Manufacturing Market Size Growth Rate by Type: 2017 VS 2021 VS 2028
1.2.2 Growth Factors
1.2.3 Interferons
1.2.4 Monoclonal Antibodies
1.2.5 Recombinant Hormones
1.2.6 Vaccines
1.2.7 Insulin
1.2.8 Others
1.3 Market by Application
1.3.1 Global Biopharmaceutical Contract Manufacturing Market Share by Application: 2017 VS 2021 VS 2028
1.3.2 Autoimmune Diseases
1.3.3 Oncology
1.3.4 Metabolic Diseases
1.3.5 Ophthalmology
1.3.6 Cardiovascular Diseases
1.3.7 Infectious Diseases
1.3.8 Neurology
1.3.9 Respiratory Disorders
1.3.10 Others
1.4 Study Objectives
1.5 Years Considered
2 Global Growth Trends
2.1 Global Biopharmaceutical Contract Manufacturing Market Perspective (2017-2028)
2.2 Biopharmaceutical Contract Manufacturing Growth Trends by Region
2.2.1 Biopharmaceutical Contract Manufacturing Market Size by Region: 2017 VS 2021 VS 2028
2.2.2 Biopharmaceutical Contract Manufacturing Historic Market Size by Region (2017-2022)
2.2.3 Biopharmaceutical Contract Manufacturing Forecasted Market Size by Region (2023-2028)
2.3 Biopharmaceutical Contract Manufacturing Market Dynamics
2.3.1 Biopharmaceutical Contract Manufacturing Industry Trends
2.3.2 Biopharmaceutical Contract Manufacturing Market Drivers
2.3.3 Biopharmaceutical Contract Manufacturing Market Challenges
2.3.4 Biopharmaceutical Contract Manufacturing Market Restraints
3 Competition Landscape by Key Players
3.1 Global Top Biopharmaceutical Contract Manufacturing Players by Revenue
3.1.1 Global Top Biopharmaceutical Contract Manufacturing Players by Revenue (2017-2022)
3.1.2 Global Biopharmaceutical Contract Manufacturing Revenue Market Share by Players (2017-2022)
3.2 Global Biopharmaceutical Contract Manufacturing Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.3 Players Covered: Ranking by Biopharmaceutical Contract Manufacturing Revenue
3.4 Global Biopharmaceutical Contract Manufacturing Market Concentration Ratio
3.4.1 Global Biopharmaceutical Contract Manufacturing Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Biopharmaceutical Contract Manufacturing Revenue in 2021
3.5 Biopharmaceutical Contract Manufacturing Key Players Head office and Area Served
3.6 Key Players Biopharmaceutical Contract Manufacturing Product Solution and Service
3.7 Date of Enter into Biopharmaceutical Contract Manufacturing Market
3.8 Mergers & Acquisitions, Expansion Plans
4 Biopharmaceutical Contract Manufacturing Breakdown Data by Type
4.1 Global Biopharmaceutical Contract Manufacturing Historic Market Size by Type (2017-2022)
4.2 Global Biopharmaceutical Contract Manufacturing Forecasted Market Size by Type (2023-2028)
5 Biopharmaceutical Contract Manufacturing Breakdown Data by Application
5.1 Global Biopharmaceutical Contract Manufacturing Historic Market Size by Application (2017-2022)
5.2 Global Biopharmaceutical Contract Manufacturing Forecasted Market Size by Application (2023-2028)
6 North America
6.1 North America Biopharmaceutical Contract Manufacturing Market Size (2017-2028)
6.2 North America Biopharmaceutical Contract Manufacturing Market Size by Country (2017-2022)
6.3 North America Biopharmaceutical Contract Manufacturing Market Size by Country (2023-2028)
6.4 United States
6.5 Canada
7 Europe
7.1 Europe Biopharmaceutical Contract Manufacturing Market Size (2017-2028)
7.2 Europe Biopharmaceutical Contract Manufacturing Market Size by Country (2017-2022)
7.3 Europe Biopharmaceutical Contract Manufacturing Market Size by Country (2023-2028)
7.4 Germany
7.5 France
7.6 U.K.
7.7 Italy
7.8 Russia
7.9 Nordic Countries
8 Asia-Pacific
8.1 Asia-Pacific Biopharmaceutical Contract Manufacturing Market Size (2017-2028)
8.2 Asia-Pacific Biopharmaceutical Contract Manufacturing Market Size by Country (2017-2022)
8.3 Asia-Pacific Biopharmaceutical Contract Manufacturing Market Size by Country (2023-2028)
8.4 China
8.5 Japan
8.6 South Korea
8.7 Southeast Asia
8.8 India
8.9 Australia
9 Latin America
9.1 Latin America Biopharmaceutical Contract Manufacturing Market Size (2017-2028)
9.2 Latin America Biopharmaceutical Contract Manufacturing Market Size by Country (2017-2022)
9.3 Latin America Biopharmaceutical Contract Manufacturing Market Size by Country (2023-2028)
9.4 Mexico
9.5 Brazil
10 Middle East & Africa
10.1 Middle East & Africa Biopharmaceutical Contract Manufacturing Market Size (2017-2028)
10.2 Middle East & Africa Biopharmaceutical Contract Manufacturing Market Size by Country (2017-2022)
10.3 Middle East & Africa Biopharmaceutical Contract Manufacturing Market Size by Country (2023-2028)
10.4 Turkey
10.5 Saudi Arabia
10.6 UAE
11 Key Players Profiles
11.1 Lonza Group
11.1.1 Lonza Group Company Detail
11.1.2 Lonza Group Business Overview
11.1.3 Lonza Group Biopharmaceutical Contract Manufacturing Introduction
11.1.4 Lonza Group Revenue in Biopharmaceutical Contract Manufacturing Business (2017-2022)
11.1.5 Lonza Group Recent Development
11.2 Baxter Biopharma Solutions
11.2.1 Baxter Biopharma Solutions Company Detail
11.2.2 Baxter Biopharma Solutions Business Overview
11.2.3 Baxter Biopharma Solutions Biopharmaceutical Contract Manufacturing Introduction
11.2.4 Baxter Biopharma Solutions Revenue in Biopharmaceutical Contract Manufacturing Business (2017-2022)
11.2.5 Baxter Biopharma Solutions Recent Development
11.3 Samsung
11.3.1 Samsung Company Detail
11.3.2 Samsung Business Overview
11.3.3 Samsung Biopharmaceutical Contract Manufacturing Introduction
11.3.4 Samsung Revenue in Biopharmaceutical Contract Manufacturing Business (2017-2022)
11.3.5 Samsung Recent Development
11.4 Fujifilm Diosynth Biotechnologies
11.4.1 Fujifilm Diosynth Biotechnologies Company Detail
11.4.2 Fujifilm Diosynth Biotechnologies Business Overview
11.4.3 Fujifilm Diosynth Biotechnologies Biopharmaceutical Contract Manufacturing Introduction
11.4.4 Fujifilm Diosynth Biotechnologies Revenue in Biopharmaceutical Contract Manufacturing Business (2017-2022)
11.4.5 Fujifilm Diosynth Biotechnologies Recent Development
11.5 Boehringer Ingelheim
11.5.1 Boehringer Ingelheim Company Detail
11.5.2 Boehringer Ingelheim Business Overview
11.5.3 Boehringer Ingelheim Biopharmaceutical Contract Manufacturing Introduction
11.5.4 Boehringer Ingelheim Revenue in Biopharmaceutical Contract Manufacturing Business (2017-2022)
11.5.5 Boehringer Ingelheim Recent Development
11.6 Patheon
11.6.1 Patheon Company Detail
11.6.2 Patheon Business Overview
11.6.3 Patheon Biopharmaceutical Contract Manufacturing Introduction
11.6.4 Patheon Revenue in Biopharmaceutical Contract Manufacturing Business (2017-2022)
11.6.5 Patheon Recent Development
11.7 Rentschler Biotechnologie
11.7.1 Rentschler Biotechnologie Company Detail
11.7.2 Rentschler Biotechnologie Business Overview
11.7.3 Rentschler Biotechnologie Biopharmaceutical Contract Manufacturing Introduction
11.7.4 Rentschler Biotechnologie Revenue in Biopharmaceutical Contract Manufacturing Business (2017-2022)
11.7.5 Rentschler Biotechnologie Recent Development
11.8 Biomeva
11.8.1 Biomeva Company Detail
11.8.2 Biomeva Business Overview
11.8.3 Biomeva Biopharmaceutical Contract Manufacturing Introduction
11.8.4 Biomeva Revenue in Biopharmaceutical Contract Manufacturing Business (2017-2022)
11.8.5 Biomeva Recent Development
11.9 Probiogen
11.9.1 Probiogen Company Detail
11.9.2 Probiogen Business Overview
11.9.3 Probiogen Biopharmaceutical Contract Manufacturing Introduction
11.9.4 Probiogen Revenue in Biopharmaceutical Contract Manufacturing Business (2017-2022)
11.9.5 Probiogen Recent Development
11.10 Cytovance Biologics
11.10.1 Cytovance Biologics Company Detail
11.10.2 Cytovance Biologics Business Overview
11.10.3 Cytovance Biologics Biopharmaceutical Contract Manufacturing Introduction
11.10.4 Cytovance Biologics Revenue in Biopharmaceutical Contract Manufacturing Business (2017-2022)
11.10.5 Cytovance Biologics Recent Development
11.11 KBI Biopharma
11.11.1 KBI Biopharma Company Detail
11.11.2 KBI Biopharma Business Overview
11.11.3 KBI Biopharma Biopharmaceutical Contract Manufacturing Introduction
11.11.4 KBI Biopharma Revenue in Biopharmaceutical Contract Manufacturing Business (2017-2022)
11.11.5 KBI Biopharma Recent Development
11.12 WuXi Biologics
11.12.1 WuXi Biologics Company Detail
11.12.2 WuXi Biologics Business Overview
11.12.3 WuXi Biologics Biopharmaceutical Contract Manufacturing Introduction
11.12.4 WuXi Biologics Revenue in Biopharmaceutical Contract Manufacturing Business (2017-2022)
11.12.5 WuXi Biologics Recent Development
11.13 Abzena
11.13.1 Abzena Company Detail
11.13.2 Abzena Business Overview
11.13.3 Abzena Biopharmaceutical Contract Manufacturing Introduction
11.13.4 Abzena Revenue in Biopharmaceutical Contract Manufacturing Business (2017-2022)
11.13.5 Abzena Recent Development
12 Analyst's Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.2 Data Source
13.2 Disclaimer
13.3 Author Details

LIST OF TABLES & FIGURES

List of Tables
Table 1. Global Biopharmaceutical Contract Manufacturing Market Size Growth Rate by Type (US$ Million): 2017 VS 2021 VS 2028
Table 2. Key Players of Growth Factors
Table 3. Key Players of Interferons
Table 4. Key Players of Monoclonal Antibodies
Table 5. Key Players of Recombinant Hormones
Table 6. Key Players of Vaccines
Table 7. Key Players of Insulin
Table 8. Key Players of Others
Table 9. Global Biopharmaceutical Contract Manufacturing Market Size Growth by Application (US$ Million): 2017 VS 2021 VS 2028
Table 10. Global Biopharmaceutical Contract Manufacturing Market Size by Region (US$ Million): 2017 VS 2021 VS 2028
Table 11. Global Biopharmaceutical Contract Manufacturing Market Size by Region (2017-2022) & (US$ Million)
Table 12. Global Biopharmaceutical Contract Manufacturing Market Share by Region (2017-2022)
Table 13. Global Biopharmaceutical Contract Manufacturing Forecasted Market Size by Region (2023-2028) & (US$ Million)
Table 14. Global Biopharmaceutical Contract Manufacturing Market Share by Region (2023-2028)
Table 15. Biopharmaceutical Contract Manufacturing Market Trends
Table 16. Biopharmaceutical Contract Manufacturing Market Drivers
Table 17. Biopharmaceutical Contract Manufacturing Market Challenges
Table 18. Biopharmaceutical Contract Manufacturing Market Restraints
Table 19. Global Biopharmaceutical Contract Manufacturing Revenue by Players (2017-2022) & (US$ Million)
Table 20. Global Biopharmaceutical Contract Manufacturing Market Share by Players (2017-2022)
Table 21. Global Top Biopharmaceutical Contract Manufacturing Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Biopharmaceutical Contract Manufacturing as of 2021)
Table 22. Ranking of Global Top Biopharmaceutical Contract Manufacturing Companies by Revenue (US$ Million) in 2021
Table 23. Global 5 Largest Players Market Share by Biopharmaceutical Contract Manufacturing Revenue (CR5 and HHI) & (2017-2022)
Table 24. Key Players Headquarters and Area Served
Table 25. Key Players Biopharmaceutical Contract Manufacturing Product Solution and Service
Table 26. Date of Enter into Biopharmaceutical Contract Manufacturing Market
Table 27. Mergers & Acquisitions, Expansion Plans
Table 28. Global Biopharmaceutical Contract Manufacturing Market Size by Type (2017-2022) & (US$ Million)
Table 29. Global Biopharmaceutical Contract Manufacturing Revenue Market Share by Type (2017-2022)
Table 30. Global Biopharmaceutical Contract Manufacturing Forecasted Market Size by Type (2023-2028) & (US$ Million)
Table 31. Global Biopharmaceutical Contract Manufacturing Revenue Market Share by Type (2023-2028)
Table 32. Global Biopharmaceutical Contract Manufacturing Market Size by Application (2017-2022) & (US$ Million)
Table 33. Global Biopharmaceutical Contract Manufacturing Revenue Market Share by Application (2017-2022)
Table 34. Global Biopharmaceutical Contract Manufacturing Forecasted Market Size by Application (2023-2028) & (US$ Million)
Table 35. Global Biopharmaceutical Contract Manufacturing Revenue Market Share by Application (2023-2028)
Table 36. North America Biopharmaceutical Contract Manufacturing Market Size by Country (2017-2022) & (US$ Million)
Table 37. North America Biopharmaceutical Contract Manufacturing Market Size by Country (2023-2028) & (US$ Million)
Table 38. Europe Biopharmaceutical Contract Manufacturing Market Size by Country (2017-2022) & (US$ Million)
Table 39. Europe Biopharmaceutical Contract Manufacturing Market Size by Country (2023-2028) & (US$ Million)
Table 40. Asia-Pacific Biopharmaceutical Contract Manufacturing Market Size by Region (2017-2022) & (US$ Million)
Table 41. Asia-Pacific Biopharmaceutical Contract Manufacturing Market Size by Region (2023-2028) & (US$ Million)
Table 42. Latin America Biopharmaceutical Contract Manufacturing Market Size by Country (2017-2022) & (US$ Million)
Table 43. Latin America Biopharmaceutical Contract Manufacturing Market Size by Country (2023-2028) & (US$ Million)
Table 44. Middle East & Africa Biopharmaceutical Contract Manufacturing Market Size by Country (2017-2022) & (US$ Million)
Table 45. Middle East & Africa Biopharmaceutical Contract Manufacturing Market Size by Country (2023-2028) & (US$ Million)
Table 46. Lonza Group Company Detail
Table 47. Lonza Group Business Overview
Table 48. Lonza Group Biopharmaceutical Contract Manufacturing Product
Table 49. Lonza Group Revenue in Biopharmaceutical Contract Manufacturing Business (2017-2022) & (US$ Million)
Table 50. Lonza Group Recent Development
Table 51. Baxter Biopharma Solutions Company Detail
Table 52. Baxter Biopharma Solutions Business Overview
Table 53. Baxter Biopharma Solutions Biopharmaceutical Contract Manufacturing Product
Table 54. Baxter Biopharma Solutions Revenue in Biopharmaceutical Contract Manufacturing Business (2017-2022) & (US$ Million)
Table 55. Baxter Biopharma Solutions Recent Development
Table 56. Samsung Company Detail
Table 57. Samsung Business Overview
Table 58. Samsung Biopharmaceutical Contract Manufacturing Product
Table 59. Samsung Revenue in Biopharmaceutical Contract Manufacturing Business (2017-2022) & (US$ Million)
Table 60. Samsung Recent Development
Table 61. Fujifilm Diosynth Biotechnologies Company Detail
Table 62. Fujifilm Diosynth Biotechnologies Business Overview
Table 63. Fujifilm Diosynth Biotechnologies Biopharmaceutical Contract Manufacturing Product
Table 64. Fujifilm Diosynth Biotechnologies Revenue in Biopharmaceutical Contract Manufacturing Business (2017-2022) & (US$ Million)
Table 65. Fujifilm Diosynth Biotechnologies Recent Development
Table 66. Boehringer Ingelheim Company Detail
Table 67. Boehringer Ingelheim Business Overview
Table 68. Boehringer Ingelheim Biopharmaceutical Contract Manufacturing Product
Table 69. Boehringer Ingelheim Revenue in Biopharmaceutical Contract Manufacturing Business (2017-2022) & (US$ Million)
Table 70. Boehringer Ingelheim Recent Development
Table 71. Patheon Company Detail
Table 72. Patheon Business Overview
Table 73. Patheon Biopharmaceutical Contract Manufacturing Product
Table 74. Patheon Revenue in Biopharmaceutical Contract Manufacturing Business (2017-2022) & (US$ Million)
Table 75. Patheon Recent Development
Table 76. Rentschler Biotechnologie Company Detail
Table 77. Rentschler Biotechnologie Business Overview
Table 78. Rentschler Biotechnologie Biopharmaceutical Contract Manufacturing Product
Table 79. Rentschler Biotechnologie Revenue in Biopharmaceutical Contract Manufacturing Business (2017-2022) & (US$ Million)
Table 80. Rentschler Biotechnologie Recent Development
Table 81. Biomeva Company Detail
Table 82. Biomeva Business Overview
Table 83. Biomeva Biopharmaceutical Contract Manufacturing Product
Table 84. Biomeva Revenue in Biopharmaceutical Contract Manufacturing Business (2017-2022) & (US$ Million)
Table 85. Biomeva Recent Development
Table 86. Probiogen Company Detail
Table 87. Probiogen Business Overview
Table 88. Probiogen Biopharmaceutical Contract Manufacturing Product
Table 89. Probiogen Revenue in Biopharmaceutical Contract Manufacturing Business (2017-2022) & (US$ Million)
Table 90. Probiogen Recent Development
Table 91. Cytovance Biologics Company Detail
Table 92. Cytovance Biologics Business Overview
Table 93. Cytovance Biologics Biopharmaceutical Contract Manufacturing Product
Table 94. Cytovance Biologics Revenue in Biopharmaceutical Contract Manufacturing Business (2017-2022) & (US$ Million)
Table 95. Cytovance Biologics Recent Development
Table 96. KBI Biopharma Company Detail
Table 97. KBI Biopharma Business Overview
Table 98. KBI Biopharma Biopharmaceutical Contract ManufacturingProduct
Table 99. KBI Biopharma Revenue in Biopharmaceutical Contract Manufacturing Business (2017-2022) & (US$ Million)
Table 100. KBI Biopharma Recent Development
Table 101. WuXi Biologics Company Detail
Table 102. WuXi Biologics Business Overview
Table 103. WuXi Biologics Biopharmaceutical Contract ManufacturingProduct
Table 104. WuXi Biologics Revenue in Biopharmaceutical Contract Manufacturing Business (2017-2022) & (US$ Million)
Table 105. WuXi Biologics Recent Development
Table 106. Abzena Company Detail
Table 107. Abzena Business Overview
Table 108. Abzena Biopharmaceutical Contract ManufacturingProduct
Table 109. Abzena Revenue in Biopharmaceutical Contract Manufacturing Business (2017-2022) & (US$ Million)
Table 110. Abzena Recent Development
Table 111. Research Programs/Design for This Report
Table 112. Key Data Information from Secondary Sources
Table 113. Key Data Information from Primary Sources
List of Figures
Figure 1. Global Biopharmaceutical Contract Manufacturing Market Share by Type: 2021 VS 2028
Figure 2. Growth Factors Features
Figure 3. Interferons Features
Figure 4. Monoclonal Antibodies Features
Figure 5. Recombinant Hormones Features
Figure 6. Vaccines Features
Figure 7. Insulin Features
Figure 8. Others Features
Figure 9. Global Biopharmaceutical Contract Manufacturing Market Share by Application in 2021 & 2028
Figure 10. Autoimmune Diseases Case Studies
Figure 11. Oncology Case Studies
Figure 12. Metabolic Diseases Case Studies
Figure 13. Ophthalmology Case Studies
Figure 14. Cardiovascular Diseases Case Studies
Figure 15. Infectious Diseases Case Studies
Figure 16. Neurology Case Studies
Figure 17. Respiratory Disorders Case Studies
Figure 18. Others Case Studies
Figure 19. Biopharmaceutical Contract Manufacturing Report Years Considered
Figure 20. Global Biopharmaceutical Contract Manufacturing Market Size (US$ Million), Year-over-Year: 2017-2028
Figure 21. Global Biopharmaceutical Contract Manufacturing Market Size, (US$ Million), 2017 VS 2021 VS 2028
Figure 22. Global Biopharmaceutical Contract Manufacturing Market Share by Region: 2021 VS 2028
Figure 23. Global Biopharmaceutical Contract Manufacturing Market Share by Players in 2021
Figure 24. Global Top Biopharmaceutical Contract Manufacturing Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Biopharmaceutical Contract Manufacturing as of 2021)
Figure 25. The Top 10 and 5 Players Market Share by Biopharmaceutical Contract Manufacturing Revenue in 2021
Figure 26. North America Biopharmaceutical Contract Manufacturing Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 27. North America Biopharmaceutical Contract Manufacturing Market Share by Country (2017-2028)
Figure 28. United States Biopharmaceutical Contract Manufacturing Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 29. Canada Biopharmaceutical Contract Manufacturing Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 30. Europe Biopharmaceutical Contract Manufacturing Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 31. Europe Biopharmaceutical Contract Manufacturing Market Share by Country (2017-2028)
Figure 32. Germany Biopharmaceutical Contract Manufacturing Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 33. France Biopharmaceutical Contract Manufacturing Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 34. U.K. Biopharmaceutical Contract Manufacturing Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 35. Italy Biopharmaceutical Contract Manufacturing Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 36. Russia Biopharmaceutical Contract Manufacturing Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 37. Nordic Countries Biopharmaceutical Contract Manufacturing Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 38. Asia-Pacific Biopharmaceutical Contract Manufacturing Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 39. Asia-Pacific Biopharmaceutical Contract Manufacturing Market Share by Region (2017-2028)
Figure 40. China Biopharmaceutical Contract Manufacturing Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 41. Japan Biopharmaceutical Contract Manufacturing Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 42. South Korea Biopharmaceutical Contract Manufacturing Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 43. Southeast Asia Biopharmaceutical Contract Manufacturing Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 44. India Biopharmaceutical Contract Manufacturing Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 45. Australia Biopharmaceutical Contract Manufacturing Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 46. Latin America Biopharmaceutical Contract Manufacturing Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 47. Latin America Biopharmaceutical Contract Manufacturing Market Share by Country (2017-2028)
Figure 48. Mexico Biopharmaceutical Contract Manufacturing Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 49. Brazil Biopharmaceutical Contract Manufacturing Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 50. Middle East & Africa Biopharmaceutical Contract Manufacturing Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 51. Middle East & Africa Biopharmaceutical Contract Manufacturing Market Share by Country (2017-2028)
Figure 52. Turkey Biopharmaceutical Contract Manufacturing Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 53. Saudi Arabia Biopharmaceutical Contract Manufacturing Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 54. Lonza Group Revenue Growth Rate in Biopharmaceutical Contract Manufacturing Business (2017-2022)
Figure 55. Baxter Biopharma Solutions Revenue Growth Rate in Biopharmaceutical Contract Manufacturing Business (2017-2022)
Figure 56. Samsung Revenue Growth Rate in Biopharmaceutical Contract Manufacturing Business (2017-2022)
Figure 57. Fujifilm Diosynth Biotechnologies Revenue Growth Rate in Biopharmaceutical Contract Manufacturing Business (2017-2022)
Figure 58. Boehringer Ingelheim Revenue Growth Rate in Biopharmaceutical Contract Manufacturing Business (2017-2022)
Figure 59. Patheon Revenue Growth Rate in Biopharmaceutical Contract Manufacturing Business (2017-2022)
Figure 60. Rentschler Biotechnologie Revenue Growth Rate in Biopharmaceutical Contract Manufacturing Business (2017-2022)
Figure 61. Biomeva Revenue Growth Rate in Biopharmaceutical Contract Manufacturing Business (2017-2022)
Figure 62. Probiogen Revenue Growth Rate in Biopharmaceutical Contract Manufacturing Business (2017-2022)
Figure 63. Cytovance Biologics Revenue Growth Rate in Biopharmaceutical Contract Manufacturing Business (2017-2022)
Figure 64. KBI Biopharma Revenue Growth Rate in Biopharmaceutical Contract Manufacturing Business (2017-2022)
Figure 65. WuXi Biologics Revenue Growth Rate in Biopharmaceutical Contract Manufacturing Business (2017-2022)
Figure 66. Abzena Revenue Growth Rate in Biopharmaceutical Contract Manufacturing Business (2017-2022)
Figure 67. Bottom-up and Top-down Approaches for This Report
Figure 68. Data Triangulation
Figure 69. Key Executives Interviewed

REPORT PURCHASE OPTIONS

USD Single User Price
USD Multi User Price
USD Enterprise Price

---- OR ----

Frequently Asked Questions ?

  • Upto 24 hrs - Working days
  • Upto 48 hrs max - Weekends and public holidays
  • Single User License
    A license granted to one user. Rules or conditions might be applied for e.g. the use of electric files (PDFs) or printings, depending on product.

  • Multi user License
    A license granted to multiple users.

  • Site License
    A license granted to a single business site/establishment.

  • Corporate License, Global License
    A license granted to all employees within organisation access to the product.
  • Online Payments with PayPal and CCavenue
  • Wire Transfer/Bank Transfer
  • Email
  • Hard Copy

Our Key Features

  • Data Accuracy and Reliability
  • Data Security
  • Customized Research
  • Trustworthy
  • Competitive Offerings
check discount